首页> 外文期刊>Journal of cardiovascular electrophysiology >Catheter-delivered cryoablation in the pediatric coronary sinus: assessing newer arrhythmia therapies.
【24h】

Catheter-delivered cryoablation in the pediatric coronary sinus: assessing newer arrhythmia therapies.

机译:儿科冠状静脉窦的导管冷冻消融:评估新的心律不齐疗法。

获取原文
获取原文并翻译 | 示例
           

摘要

Cryothermal (Cryo)-energy tissue delivery, utilizing handheld probes, was the mainstay of arrhythmia surgery throughout thel980s, becoming the "gold standard," with success rates better than pharmacologic therapy of the time. However, the surgical nature of the procedure itself with need for open thoracotomy, cardiopulmonary bypass, and combination skills and cooperation between the electrophysiologist and surgeon, often with custom-fabricated epicardial "mapping" electrodes, made this a long and tedious intervention, and not without typical surgical morbidities. In this regard, the evolution of effective radiofrequency (RF) catheter delivery systems was seen as an advantage in arrhythmia intervention associated with less comorbidities, even in children. However, RF energy application intrinsically is associated with technical limitations. Lesions are relatively deep, with large areas and volume, potentially causing adverse collateral tissue damage. The inherent capability of cryoablation to first "map" a potential arrhythrnogenic site by reversible extracellular cooling with high temperatures (0degC to -15degC) has distinct advantages over RF applications. With Cryo, if the reversible thermal application is found to be effective and safe, lower tissue temperatures to -70degC can then be applied, associated with production of a permanent lesion by intracellular disruption of organelles and cell membranes. A comparable analogy is the difference between applying an ice cube and dry ice. This reversing capability is absent with RF and has made Cryo technology ideal for application in smaller hearts and any arrhythrnogenic substrate close to the normal conduction tissue. In addition, the potential for less collateral damage makes its application attractive in preventing vascular damage. The evolution of catheter from hand-probe cryoablation delivery technology during the 1990s has now extended its use from the operative field into catheter-ization laboratory. Although perhaps more utilized in older patients than children, catheter-delivered cryoablation is currently becoming part of the standard ablative technologies for various arrhythmias in Pediatric Electrophysiology centers. The application of this technology into the coronary sinus of children, however, is still an evolving concept.
机译:利用手持式探头进行低温(Cryo)能量组织输送是整个20世纪90年代心律不齐手术的主要手段,成为“黄金标准”,其成功率优于当时的药物疗法。但是,该过程本身的外科手术性质需要开胸,切开体外循环,并且需要结合电生理学家和外科医生之间的配合技巧以及合作,通常需要定制的心外膜“映射”电极,这使得这种手术既冗长又乏味,并且没有没有典型的手术发病率。在这方面,有效的射频(RF)导管输送系统的演进被视为与较少合并症相关的心律失常干预的一个优势,即使在儿童中也是如此。然而,RF能量的应用本质上与技术限制有关。病变相对较深,具有较大的面积和体积,可能导致不利的副组织损伤。通过高温(0℃至-15℃)可逆的细胞外冷却,冷冻消融首先“定位”潜在的致死性致死部位的固有能力相对于RF应用具有明显的优势。使用Cryo,如果发现可逆热疗是有效和安全的,则可以采用较低的组织温度至-70℃,并伴随细胞内细胞器和细胞膜的破坏产生永久性病变。一个可比的类比是应用冰块和干冰之间的区别。 RF不具备这种反转能力,因此Cryo技术非常适合在较小的心脏以及靠近正常传导组织的任何致心律失常的基质中应用。另外,潜在的较少的附带损害使其在防止血管损害方面具有吸引力。导管在1990年代从手探针冷冻消融术的发展演变到现在已从手术领域扩展到导管实验室。尽管在老年患者中使用的冷冻消融可能比儿童更多,但目前在儿科电生理中心,导管输送冷冻消融已成为各种心律不齐标准消融技术的一部分。然而,这项技术在儿童冠状窦中的应用仍然是一个不断发展的概念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号